Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and efficacy of inhaled sodium bicarbonate in cystic fibrosis
2015-000513-48Phase 2Terminated
- Sponsor
- Istituto Giannina Gaslini
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sodium bicarbonate in cystic fibrosis (CF), sponsored by Istituto Giannina Gaslini. Primary endpoint: Short-term safety (adverse events within 1 hour). Started Sep 2016; status: terminated.
02
Drugs
sodium bicarbonate
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2015-000513-48.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000513-48.